The U.S. Supreme Court has declined to hear significant patent eligibility appeals, notably in the case of Audio Evolution Diagnostics. The U.S. Court of Federal Claims invalidated AED’s patent claims, combining novelty and obviousness with patent eligibility, leading to confusion about the boundaries of eligibility. Courts have continued to apply a muddled approach to Section 101, leaving inventors uncertain about patentability. This creates detrimental effects on innovation in sectors such as medical diagnostics and computer technology.
The U.S. Supreme Court has repeatedly declined to take patent eligibility cases, creating chaos around Section 101 that threatens American innovation and economic security.
The U.S. Court of Federal Claims invalidated all of AED's patent claims, conflating novelty and obviousness with patent eligibility under Section 101.
Collection
[
|
...
]